TITLE

HIGH RATE OF MUTATION K103N CAUSING RESISTANCE TO NEVIRAPINE IN INDIAN CHILDREN WITH ACQUIRED IMMUNODEFICIENCY SYNDROME

PUB. DATE
October 2008
SOURCE
Indian Journal of Medical Microbiology;Oct2008, Vol. 26 Issue 4, p372
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
35214849

 

Related Articles

  • Nevirapine Resistance by Timing of HIV Type 1 Infection in Infants Treated with Single-Dose Nevirapine. Micek, Mark A.; Blanco, Ana Judith; Beck, Ingrid A.; Dross, Sandra; Matunha, Laurinda; Montoya, Pablo; Seidel, Kristy; Gantt, Soren; Matediane, Eduardo; Jamisse, Lilia; Gloyd, Stephen; Frenkel, Lisa M. // Clinical Infectious Diseases;5/15/2010, Vol. 50 Issue 10, p1405 

    Background. In women, single-dose nevirapine for prophylaxis against mother-to-child transmission of human immunodeficiency virus type 1 (HIV-1) selects for nevirapine-resistant HIV-1, which subsequently decays rapidly. We hypothesized that the selection, acquisition, and decay of...

  • Induction Therapy with Protease-Inhibitors Modifies the Effect of Nevirapine Resistance on Virologic Response to Nevirapine-based HAART in Children. Moorthy, Anitha; Kuhn, Louise; Coovadia, Ashraf; Meyers, Tammy; Strehlau, Renate; Sherman, Gayle; Wei-Yann Tsai; Ya Hui Chen; Abrams, Elaine J.; Persaud, Deborah // Clinical Infectious Diseases;2/15/2011, Vol. 52 Issue 4, p514 

    Background. Nevirapine resistance after failed prophylaxis to prevent mother-to-child human immunodeficiency virus (HIV) transmission can compromise subsequent nevirapine-based highly active antiretroviral therapy (HAART). Methods. Nevirapine-exposed children who achieved virologic suppression...

  • Nevirapine: A Review of its Use in the Prevention and Treatment of Paediatric HIV Infection. Bardsley-Elliot, A.; Perry, C.M. // Pediatric Drugs;Sep/Oct2000, Vol. 2 Issue 5, p373 

    Nevirapine is a highly specific inhibitor of HIV-1 reverse transcriptase (RT), an important therapeutic target for the treatment of HIV infection. It was the first non-nucleoside RT inhibitor (NNRTI) to be approved for use in HIV-infected individuals, including children. Nevirapine inhibits...

  • Resistance mutations may be decreasing among children with HIV.  // Infectious Diseases in Children;Oct2011, Vol. 24 Issue 10, p15 

    The article focuses on a study which examined the incidence rate of resistance mutations by antiretroviral class in children with human immunodeficiency virus (HIV).

  • NMR characterization of HIV-1 reverse transcriptase binding to various non-nucleoside reverse transcriptase inhibitors with different activities. Thammaporn, Ratsupa; Yagi-Utsumi, Maho; Yamaguchi, Takumi; Boonsri, Pornthip; Saparpakorn, Patchreenart; Choowongkomon, Kiattawee; Techasakul, Supanna; Kato, Koichi; Hannongbua, Supa // Scientific Reports;10/30/2015, p15806 

    Human immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT) is an important target for antiviral therapy against acquired immunodeficiency syndrome. However, the efficiency of available drugs is impaired most typically by drug-resistance mutations in this enzyme. In this study, we...

  • Overview of HIV/AIDS in India. Marfatia, Y. S.; Sharma, Archana; Modi, Megha // Indian Journal of Sexually Transmitted Diseases;2007, Vol. 28 Issue 1, p1 

    Globally there are 40 million people living with human immunodeficiency virus (HIV)/ acquired immunodefi ciency syndrome (AIDS). According to latest estimates based on National Family Health Survey (NFHS), released by National AIDS Control Organization (NACO), the National adult HIV prevalence...

  • Nevirapine.  // AHFS Consumer Medication Information;Jan2020, p1 

    Nevirapine is used in combination with other medications to treat human immunodeficiency virus (HIV) infection in patients with or without acquired immunodeficiency syndrome (AIDS). Nevirapine is in a class of medications called non-nucleoside reverse transcriptase inhibitors (NNRTIs). It works...

  • Substitution of Nevirapine, Efavirenz, or Abacavir for Protease Inhibitors in Patients with Human Immunodeficiency Virus Infection. Martínez, Esteban; Arnaiz, Juan A.; Podzamczer, Daniel; Dalmau, David; Ribera, Esteban; Domingo, Pere; Knobel, Hernando; Riera, Melcior; Pedrol, Enric; Force, Lluis; Llibre, Josep M.; Segura, Ferran; Richart, Cristóbal; Cortés, Cristina; Javaloyas, Manuel; Aranda, Miquel; Cruceta, Ana; de Lazzari, Elisa; Gatell, José M. // New England Journal of Medicine;9/11/2003, Vol. 349 Issue 11, p1036 

    Background: We assessed the strategy of substituting nevirapine, efavirenz, or abacavir for a protease inhibitor in patients infected with human immunodeficiency virus type 1 (HIV-1) in whom virologic suppression had been achieved. Methods: We randomly assigned 460 adults who were taking two...

  • Methicillin-Resistant Staphylococcus aureus Infection in the Texas Prison System. Baillargeon, Jacques; Kelley, Michael F.; Leach, Charles T.; Baillargeon, Gwen; Pollock, Brad H. // Clinical Infectious Diseases;5/1/2004, Vol. 38 Issue 9, pe92 

    Recent reports indicate that correctional facility inmates may be at elevated risk for contracting methicillin-resistant Staphylococcus aureus (MRSA) infection because of overcrowding, poor hygiene, and high rates of diseases causing immunosuppression. The present study of 299,179 Texas inmates...

  • Once-daily dosing of nevirapine in HAART.  // Journal of Antimicrobial Chemotherapy (JAC);Jan2008, Vol. 61 Issue 1, p13 

    Non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimens provide simpler and more easily tolerated treatment alternatives to protease inhibitor-based regimens, potentially improving adherence. Long-term viral suppression relies on adherence to a prescribed antiretroviral treatment...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics